pharma operations – Page 70

Data integrity red flags during sample management – CAPA package with objective evidence

Identifying and Addressing Data Integrity Red Flags During Sample Management Data integrity is a cornerstone of quality assurance in the pharmaceutical industry. However, during sample management, several indicators can signal…

System suitability failure ignored in routine release testing – FDA data integrity risk and corrective actions

Addressing System Suitability Failures in Routine Release Testing: Investigation and CAPA Insights In the realm of pharmaceutical quality control, the integrity of release testing processes is crucial. A frequent issue…

Instrument qualification gap in stability testing – FDA data integrity risk and corrective actions

Investigating Instrument Qualification Gaps in Stability Testing: Risks and Corrective Actions Instrument qualification is fundamental to ensure compliance in pharmaceutical quality control processes, particularly in stability testing. A significant gap…

Sample handling deviation during inspection data walkthrough – improving right-first-time testing metrics

Investigation of Sample Handling Deviations During Inspection Data Walkthroughs Pharmaceutical manufacturing is a highly regulated and precision-driven field. Quality Control (QC) serves as a critical element in ensuring that products…

OOS investigation lacks root cause in stability testing – improving right-first-time testing metrics

Improving Right-First-Time Testing Metrics in OOS Investigations for Stability Testing Investigating out-of-specification (OOS) results from stability testing poses a significant challenge in pharmaceutical quality control. These investigations often reveal complex…

Inadequate risk assessment during regulatory inspection readiness – regulatory expectation gap and how to fix it

Addressing Gaps in Risk Assessment for Regulatory Inspections: Practical Solutions Pharmaceutical manufacturing faces complex challenges, especially regarding regulatory inspections. Instances of inadequate risk assessment during preparation can lead to significant…

Quality event trending ignored during internal audit follow-up – how to prevent repeat observations

Addressing Trends in Quality Events Ignored During Internal Audits to Prevent Recurrences In pharmaceutical manufacturing, quality assurance (QA) is paramount, and internal audits are a critical component of maintaining compliance…

Inconsistent SOP interpretation during complaint triage – GDP documentation do’s and don’ts

Addressing the Challenges of SOP Interpretation During Complaint Triage in Pharma Operations In the dynamic environment of pharmaceutical manufacturing, the adherence to Standard Operating Procedures (SOPs) is crucial for ensuring…

Batch disposition delayed during change control governance – how to prevent repeat observations

Addressing Delays in Batch Disposition During Change Control Governance In the fast-paced environment of pharmaceutical manufacturing, delays in batch disposition can have significant ramifications beyond mere operational efficiency. Such delays…

Batch disposition delayed during QA review – risk-based justification template for decisions

Addressing Delays in Batch Disposition During Quality Assurance Review Delays in batch disposition during the Quality Assurance (QA) review process can have significant implications for pharmaceutical operations. These delays may…

Inconsistent SOP interpretation during management review – risk-based justification template for decisions

Addressing Inconsistent SOP Interpretations during Management Reviews in Pharma Operations Inconsistent Standard Operating Procedure (SOP) interpretations during management reviews can lead to significant operational risks, affecting product quality and compliance…

Supplier deviation not assessed during complaint triage – CAPA effectiveness verification framework

Assessing Supplier Deviations During Complaint Triage: A Framework for CAPA Effectiveness Verification In pharmaceutical manufacturing, the integrity of raw materials and components is crucial to ensuring product quality and compliance.…